GPGhislaine Prévot

Ghislaine Prévot

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ghislaine Prévot has a total of 157 co-authors. Here are the top co-authors by number of shared publications:

  • Eliane Bourreau

    Institut Pasteur de la Guyane, 23 Avenue Pasteur, BP6010, 97306, Cayenne Cedex, French Guiana

    12 shared publications
  • Marine Ginouves

    Laboratoire Tropical Biome and ImmunoPathophysiology (TBIP), Université de Guyane, Cayenne, French Guiana

    8 shared publications
  • Marine Ginouves

    Ecosystèmes Amazoniens et Pathologie Tropicale, EA 3593, Medicine Department, University of French Guiana, Cayenne, French Guiana

    6 shared publications
  • Pascal Launois

    Immunologie des Leishmanioses

    6 shared publications
  • Roger Pradinaud

    Immunologie des Leishmanies, Institut Pasteur de la Guyane,1 Institut d'Etudes Supérieures de la Guyane, Université Antilles-Guyane,2 Institut Guyanais de Dermatologie Tropicale, Centre Hospitalier Andrée Rosemon, Cayenne, French Guyana,3 Mycobacterial Immunology, Pasteur Institute of Brussels, Brussels, Belgium4

    6 shared publications
  • Magalie Demar

    Laboratory of Microbiology, Cayenne General Hospital, Cayenne, French Guiana

    5 shared publications

Latest Publications

  • Associations Between Serum Activin A and Follistatine-Like 3 Levels and Outcomes in Pulmonary Arterial Hypertension

    by C. Guignabert, L. Savale, A. Boucly, R. Thuillet, L. Tu, M. Ottaviani, C.J. Rhodes, P. De Groote, G. Prévot, E. Bergot, et al.

  • Treating leishmaniasis in Amazonia, part 2: Multi-target evaluation of widely used plants to understand medicinal practices

    by Emeline Houël, Marine Ginouves, Nadine Azas, Eliane Bourreau, Véronique Eparvier, Sébastien Hutter, Adeline Knittel-Obrecht, Arnaud Jahn-Oyac, Ghislaine Prévot, Pascal Villa, et al.


  • Biodiversity and vector‐borne diseases: Host dilution and vector amplification occur simultaneously for Amazonian leishmaniases

    by Arthur Kocher, Josselin Cornuault, Jean‐Charles Gantier, Sophie Manzi, Agathe Chavy, Romain Girod, Isabelle Dusfour, Pierre‐Michel Forget, Marine Ginouves, Ghislaine Prévot, et al.

    Changes in biodiversity may impact infectious disease transmission through multiple mechanisms. We explored the impact of biodiversity changes on the transmission of Amazonian leishmaniases, a group of wild zoonoses transmitted by phlebotomine sand flies (Psychodidae), which represent an important health burden in a region where biodiversity is both rich and threatened. Using molecular analyses of sand fly pools and blood‐fed dipterans, we characterized the disease system in forest sites in French Guiana undergoing different levels of human‐induced disturbance. We show that the prevalence of Leishmania parasites in sand flies correlates positively with the relative abundance of mammal species known as Leishmania reservoirs. In addition, Leishmania reservoirs tend to dominate in less diverse mammal communities, in accordance with the dilution effect hypothesis. This results in a negative relationship between Leishmania prevalence and mammal diversity. On the other hand, higher mammal diversity is associated with higher sand fly density, possibly because more diverse mammal communities harbor higher biomass and more abundant feeding resources for sand flies, although more research is needed to identify the factors that shape sand fly communities. As a consequence of these antagonistic effects, decreased mammal diversity comes with an increase of parasite prevalence in sand flies, but has no detectable impact on the density of infected sand flies. These results represent additional evidence that biodiversity changes may simultaneously dilute and amplify vector‐borne disease transmission through different mechanisms that need to be better understood before drawing generalities on the biodiversity‐disease relationship.


  • Leishmaniavirus genetic diversity is not related to leishmaniasis treatment failure

    by M. Ginouvès, P. Couppié, S. Simon, E. Bourreau, S. Rogier, P. Brousse, P. Travers, V. Pommier de Santi, M. Demar, S. Briolant, et al.


  • Open Access

    Ecological aspects of Phlebotomines (Diptera: Psychodidae) and the transmission of American cutaneous leishmaniasis agents in an Amazonian/ Guianan bordering area

    by Thiago Vasconcelos dos Santos, Ghislaine Prévot, Marine Ginouvès, Rosemere Duarte, Fernando Tobias Silveira, Marinete Marins Póvoa, Elizabeth Ferreira Rangel

    An entomological study was conducted in the municipality of Oiapoque (lower Oyapock River Basin) in the Brazilian side bordering French Guiana to gain information on the transmission pattern of American cutaneous leishmaniasis (ACL) in that region, presumed to reflect the classical Amazonian/Guianan enzootic scenario. Three ecologically isolated forested areas near urban environments were surveyed during the rainy and dry seasons of 2015 and 2016, using a multi-trapping approach comprising ground-level and canopy light traps, black and white colored cloth Shannon traps and manual aspiration on tree bases. Female phlebotomines were dissected to find infections and isolate flagellates from Leishmania spp. The strains were characterized by restriction fragment length polymorphism analysis and compared with those of local ACL cases and World Health Organization reference strains. Nyssomyia umbratilis, Trichopygomyia trichopyga and Evandromyia infraspinosa were the most frequently found species. Findings on relative abundance, spatiotemporal vector/ACL congruence, natural infections and anthropophilic insights strengthened the Guianan classical transmission of Leishmania (Viannia) guyanensis by Ny. umbratilis and suggested further investigations for Ev. infraspinosa. Nyssomyia umbratilis showed an eclectic feeding habit, including bird blood. Ecological data and literature reports also included Psychodopygus squamiventris maripaensis and Bichromomyia flaviscutellata on the list of suspected vectors. These findings contributed to understanding ACL ecoepidemiology in the Amazonian/Guianan scenario. Local studies are required to better comprehend the Leishmania spp. enzootic mosaic in specific ecotopes.


  • Use of the intramuscular route to administer pentamidine isethionate in Leishmania guyanensis cutaneous leishmaniasis increases the risk of treatment failure

    by Jacques-Robert Christen, Eliane Bourreau, Magalie Demar, Edward Lightburn, Pierre Couppié, Marine Ginouvès, Ghislaine Prévot, Jean-Pierre Gangneux, Hélène Savini, Frank de Laval, et al.


  • Corrigendum of the article: ‘Composition and antifungal activity of the essential oil of Nashia inaguensis Millsp. (Verbenaceae) cultivated in French Guiana’ published in the journal of essential oil research (DOI: 10.1080/10412905.2016.1142477)

    by Camille Scotto, Pauline Burger, Mehdi Khodjet el Khil, Marine Ginouves, Ghislaine Prevot, Denis Blanchet, Piero G. Delprete, Xavier Fernandez

    In a recent publication (DOI: 10.1080/10412905.2016.1142477), we presented the composition and antifungal activity of the essential oil of allegedly Nashia inaguensis Millsp. (Verbenaceae) using material from plants cultivated in French Guiana. A recent taxonomic revision of the genus Nashia, including a complete description of N. inaguensis, called our attention, as certain morphological characters did not correspond with those of our voucher specimen. An accurate re-examination of the voucher specimen and the original cultivated plants, and a comparison with the complete description of Lippia species present in the Guianas, confirmed that the species we studied was actually L. micromera Schauer. The present corrigendum aims to revise the botanical characterization presented in the aforementioned article. The chemical composition and antifungal activity of the essential oil of interest are then discussed in light of this corrected taxonomic identification in comparison with previous studies of L. micromera essential oil. The authors apologize for the error.


  • Open Access

    Unraveling the genetic diversity and phylogeny of Leishmania RNA virus 1 strains of infected Leishmania isolates circulating in French Guiana

    by Sourakhata Tirera, Marine Ginouves, Damien Donato, Ignacio S. Caballero, Christiane Bouchier, Anne Lavergne, Eliane Bourreau, Emilie Mosnier, Vincent Vantilcke, Pierre Couppié, et al.

    Leishmania RNA virus type 1 (LRV1) is an endosymbiont of some Leishmania (Vianna) species in South America. Presence of LRV1 in parasites exacerbates disease severity in animal models and humans, related to a disproportioned innate immune response, and is correlated with drug treatment failures in humans. Although the virus was identified decades ago, its genomic diversity has been overlooked until now. We subjected LRV1 strains from 19 L. (V.) guyanensis and one L. (V.) braziliensis isolates obtained from cutaneous leishmaniasis samples identified throughout French Guiana with next-generation sequencing and de novo sequence assembly. We generated and analyzed 24 unique LRV1 sequences over their full-length coding regions. Multiple alignment of these new sequences revealed variability (0.5%–23.5%) across the entire sequence except for highly conserved motifs within the 5’ untranslated region. Phylogenetic analyses showed that viral genomes of L. (V.) guyanensis grouped into five distinct clusters. They further showed a species-dependent clustering between viral genomes of L. (V.) guyanensis and L. (V.) braziliensis, confirming a long-term co-evolutionary history. Noteworthy, we identified cases of multiple LRV1 infections in three of the 20 Leishmania isolates. Here, we present the first-ever estimate of LRV1 genomic diversity that exists in Leishmania (V.) guyanensis parasites. Genetic characterization and phylogenetic analyses of these viruses has shed light on their evolutionary relationships. To our knowledge, this study is also the first to report cases of multiple LRV1 infections in some parasites. Finally, this work has made it possible to develop molecular tools for adequate identification and genotyping of LRV1 strains for diagnostic purposes. Given the suspected worsening role of LRV1 infection in the pathogenesis of human leishmaniasis, these data have a major impact from a clinical viewpoint and for the management of Leishmania-infected patients. Leishmaniasis is a well-known parasitosis due to an infection by the protozoan Leishmania parasites firmly established in South America. In French Guiana, where leishmaniasis is a public health problem, having an annual incidence of 5.6 cases/10,000 inhabitants, 80% of Leishmania spp. parasites are infected by an endosymbiotic virus, Leishmania RNA virus 1 (LRV1). The purpose of this study was to gain insights on the genetic variability and evolution of LRV1 at the genomic level. We subjected 20 Leishmania isolates obtained from cutaneous lesions with next generation sequencing and de novo sequence assembly. This allowed generating 24 LRV1 full-length coding sequences presenting among themselves a significant genetic diversity. The inferred phylogenetic relationships enabled to identify distinct well-supported genotypes and support the hypothesis of co-evolution between LRV1 strains and their parasite hosts. In addition, we identified multiple LRV1 infections in three parasite isolates. Based on these data, future characterization of new strains from other geographic areas and other parasite species should extend knowledge of LRV1 diversification processes. Finally, these results allowed us to identify genomic regions where best to allocate resources for subsequent analyses of LRV1 viral diversity and genotyping that could serve for accurate routine molecular diagnostic applications.


  • Open Access

    NaturalLeishmania(Viannia) infections of phlebotomines (Diptera: Psychodidae) indicate classical and alternative transmission cycles of American cutaneous leishmaniasis in the Guiana Shield, Brazil

    by Adelson Alcimar Almeida de Souza, Iorlando da Rocha Barata, Maria das Graças Soares Silva, José Aprígio Nunes Lima, Yara Lúcia Lins Jennings, Edna Aoba Yassui Ishikawa, Ghislaine Prévot, Marine Ginouves, Fernando Tobias Silveira, Jeffrey Shaw, et al.

    Parasite international open-access, peer-reviewed, online journal publishing high quality papers on all aspects of human and animal parasitology


  • Open Access

    In Vitro Sensitivity of Cutaneous Leishmania Promastigote Isolates Circulating in French Guiana to a Set of Drugs

    by Marine Ginouvès, Stéphane Simon, Mathieu Nacher, Magalie Demar, Bernard Carme, Pierre Couppié, Ghislaine Prévot

    Anti-leishmaniasis drug resistance is a common problem worldwide. The aim of this study was to inventory the general in vitro level of sensitivity of Leishmania isolates circulating in French Guiana and to highlight potential in vitro pentamidine-resistant isolates. This sensitivity study was conducted on 36 patient-promastigote isolates for seven drugs (amphotericin B, azithromycin, fluconazole, meglumine antimoniate, miltefosine, paromomycin, and pentamidine) using the Cell Counting Kit-8 viability test. The IC50 values obtained were heterogeneous. One isolate exhibited high IC50 values for almost all drugs tested. Pentamidine, which is the first-line treatment in French Guiana, showed efficacy at very low doses (mean of 0.0038 μg/mL). The concordance of the in vitro pentamidine results with the patients' clinical outcomes was 94% (K = 0.82).